Sequent Scientific Ltd.
Snapshot View

View in App

Prices View details >>

71.76 -1.89 ▼-2.6%

24 March 2023, 04:01:00 PM
Volume: 185,205

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sequent.in
Market Cap 1,789.93 Cr.
Enterprise Value(EV) 2,130.48 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.71 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-12
Industry PE 31.87 Trailing Twelve Months Ending 2022-12
Book Value / Share 25.09 Trailing Twelve Months Ending 2022-12
Price to Book Value 2.86 Calculated using Price: 71.76
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 24.94 Cr. 249,433,495 Shares
FaceValue 2
Company Profile
Sequent Scientific earlier known as P I Drugs & Pharmaceuticals is an integrated pharmaceutical company. Hon'ble High Court of Bombay approved the Scheme of Amalgamation of company with P I Drugs & Pharmaceuticals Ltd. Pursuant to the Scheme of Amalgamation as approved by the Honourable High Court Bombay vide its order dated June 16, 2009 Company made requisite application to the Registrar of Companies Mumbai for change of its name from PI Drugs & Pharmaceuticals Ltd. to Sequent Scientific Ltd. Accordingly Registrar of Companies approved the application and issued fresh Certificate of Incorporation consequent upon change in name dated October 27, 2009 and with effect from the date the name of Company changed to Sequent Scientific Ltd.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.57%
1 Week
-1.44%
1 Month
+7.51%
3 Month
-13.75%
6 Month
-32.75%
1 Year
-48.54%
2 Year
-70.88%
5 Year
-10.86%
10 Year
+184.42%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -201.83 -28.10 -3.35 -1.74 54.15 8.63 12.06 15.00 6.60
Return on Capital Employed (%) -16.09 6.93 2.72 0.87 41.28 9.24 12.59 16.24 7.06
Return on Assets (%) -18.19 -1.52 -1.33 -0.95 26.54 4.14 5.73 7.19 3.09

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 57 91 946 977 648 707 687 728 692 738
Non Curr. Liab. 159 278 300 246 227 215 216 154 199 175
Curr. Liab. 405 406 290 664 431 440 515 513 537 499
Minority Int. 5 147 2 17 37 40 45 49 48 44
Equity & Liab. 626 922 1,538 1,904 1,343 1,402 1,463 1,443 1,477 1,456
Non Curr. Assets 360 612 1,047 1,176 805 796 739 676 665 685
Curr. Assets 266 310 491 728 538 606 724 767 812 771
Misc. Exp. not W/O
Total Assets 626 922 1,538 1,904 1,343 1,402 1,463 1,443 1,477 1,456

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 455 465 625 684 1,031 1,039 1,179 1,362 1,413 1,438
Other Income 4 10 14 11 17 9 10 10 11 8
Total Income 459 475 639 695 1,048 1,048 1,189 1,372 1,424 1,446
Total Expenditure -439 -445 -568 -643 -919 -914 -1,009 -1,152 -1,303 -1,389
PBIDT 21 30 71 52 129 134 180 220 120 57
Interest -39 -44 -39 -28 -40 -33 -36 -24 -16 -31
Depreciation -33 -33 -46 -40 -53 -42 -51 -51 -51 -52
Taxation -1 -3 -3 0 -13 -2 -12 -32 -8 10
Exceptional Items -59 38 409 -9 -3
PAT -110 -12 -16 -16 431 57 82 104 45 -19
Minority Interest 1 -2 3 -9 -8 -12 -9 -4 1
Share Associate
Other Related Items
Consolidated Net Profit -110 -11 -18 -14 422 49 70 95 41 -18
Adjusted EPS -8 -1 -1 -1 17 2 3 4 2 -1

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -4 -45 -24 0 -7 45 116 115 115 31
Cash Fr. Inv. -55 -80 -155 -316 -116 7 -68 -72 10 -96
Cash Fr. Finan. 35 146 179 309 147 -57 -20 -43 -139 67
Net Change -24 21 1 -7 24 -5 28 0 -14 2
Cash & Cash Eqvt 3 23 22 20 44 40 68 68 54 58

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 53.86 53.86 53.86 53.52 53.02 53.02 52.79 52.79 52.79
Public 46.14 46.14 46.14 46.48 46.98 46.98 47.21 47.21 47.21
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 08 Mar 2023
Announcement under Regulation 30 (LODR)-Updates on Acquisition
We refer to our announcement on November 07 2022 regarding acquisition of 100% stake in Tineta Pharma Private limited (Tineta) by the Company it is hereby informed that the transaction contemplated under the Share Purchase Agreement has not been materialized. Therefore the Company will not acquire Tineta and the Share Purchase Agreement entered by the Company with Tineta and its Promoters on November 07 2022 stands terminated.
Tue, 21 Feb 2023
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the Earnings Call Transcript pertaining to the Unaudited Financial Results of the Company for quarter and nine months ended December 31 2022.
Thu, 16 Feb 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the provision of Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copies of advertisement published on February 16 2023 in Financial Express and Mumbai Lakshadeep newspaper providing Extracts of Unaudited Financial Results of the Company for the quarter and nine months ended December 31 2022.

Technical Scans View Details >>

Fri, 24 Mar 2023
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days
Making Lower Lows for 3 days Making Lower Lows for 3 days
Close Below Last Week Low Close Below Last Week Low

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 233,407.31 972.80 -0.5%
Divi's Laboratories Ltd. 74,497.12 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. 74,309.73 4,462.75 +0.3%
Cipla Ltd. 70,787.11 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. 61,557.09 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. 51,379.40 1,517.75 -0.9%
Zydus Lifesciences Ltd. 48,636.41 480.50 -0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 55.42 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.11 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.39 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 26.83 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.33 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.81 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.60 480.50 -0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.22 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.99 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.38 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-12 3.12 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 9.96 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.06 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.82 480.50 -0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 0.04 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 480.50 -0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 13.10 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 480.50 -0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 480.50 -0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 972.80 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,809.00 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,462.75 +0.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 877.00 +0.9%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.25 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,517.75 -0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 480.50 -0.4%

FAQ's On Sequent Scientific Ltd.

What is Sequent Scientific share price?
Can I buy Sequent Scientific shares now?
What is the Market Cap of Sequent Scientific?
What are the key metrics to analyse Sequent Scientific?
What is the 52 Week High and Low of Sequent Scientific?
What is the trend of Sequent Scientific share price?